Medtronic Gross Margin 2010-2024 | MDT
Medtronic Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2024-01-31 | $32.32B | $21.17B | 65.50% |
2023-10-31 | $31.96B | $20.90B | 65.40% |
2023-07-31 | $31.56B | $20.73B | 65.68% |
2023-04-30 | $31.23B | $20.51B | 65.67% |
2023-01-31 | $30.77B | $20.44B | 66.43% |
2022-10-31 | $30.81B | $20.71B | 67.21% |
2022-07-31 | $31.07B | $21.01B | 67.61% |
2022-04-30 | $31.69B | $21.54B | 67.98% |
2022-01-31 | $31.79B | $21.58B | 67.89% |
2021-10-31 | $31.80B | $21.43B | 67.39% |
2021-07-31 | $31.60B | $21.02B | 66.53% |
2021-04-30 | $30.12B | $19.63B | 65.19% |
2021-01-31 | $27.93B | $17.83B | 63.85% |
2020-10-31 | $27.87B | $17.99B | 64.57% |
2020-07-31 | $27.93B | $18.36B | 65.76% |
2020-04-30 | $28.91B | $19.49B | 67.41% |
2020-01-31 | $31.06B | $21.42B | 68.96% |
2019-10-31 | $30.89B | $21.38B | 69.22% |
2019-07-31 | $30.67B | $21.35B | 69.62% |
2019-04-30 | $30.56B | $21.40B | 70.04% |
2019-01-31 | $30.56B | $21.49B | 70.32% |
2018-10-31 | $30.38B | $21.38B | 70.38% |
2018-07-31 | $29.95B | $21.03B | 70.22% |
2018-04-30 | $29.95B | $20.89B | 69.73% |
2018-01-31 | $29.73B | $20.62B | 69.36% |
2017-10-31 | $29.64B | $20.46B | 69.02% |
2017-07-31 | $29.93B | $20.55B | 68.65% |
2017-04-30 | $29.71B | $20.42B | 68.72% |
2017-01-31 | $29.36B | $20.14B | 68.60% |
2016-10-31 | $29.01B | $19.92B | 68.66% |
2016-07-31 | $28.73B | $19.78B | 68.85% |
2016-04-30 | $28.83B | $19.69B | 68.29% |
2016-01-31 | $28.57B | $18.86B | 66.00% |
2015-10-31 | $25.95B | $17.25B | 66.48% |
2015-07-31 | $23.26B | $15.60B | 67.07% |
2015-04-30 | $20.26B | $13.95B | 68.86% |
2015-01-31 | $17.52B | $12.98B | 74.06% |
2014-10-31 | $17.37B | $12.90B | 74.27% |
2014-07-31 | $17.20B | $12.78B | 74.32% |
2014-04-30 | $17.01B | $12.67B | 74.52% |
2014-01-31 | $16.90B | $12.60B | 74.58% |
2013-10-31 | $16.76B | $12.52B | 74.68% |
2013-07-31 | $16.67B | $12.49B | 74.95% |
2013-04-30 | $16.59B | $12.46B | 75.13% |
2013-01-31 | $16.43B | $12.39B | 75.41% |
2012-10-31 | $16.32B | $12.35B | 75.66% |
2012-07-31 | $16.25B | $12.34B | 75.93% |
2012-04-30 | $16.18B | $12.30B | 75.97% |
2012-01-31 | $15.86B | $12.11B | 76.33% |
2011-10-31 | $15.80B | $12.04B | 76.22% |
2011-07-31 | $15.68B | $11.92B | 76.03% |
2011-04-30 | $15.51B | $11.81B | 76.14% |
2011-01-31 | $15.30B | $11.73B | 76.67% |
2010-10-31 | $15.30B | $11.75B | 76.81% |
2010-07-31 | $15.23B | $11.72B | 76.96% |
2010-04-30 | $15.39B | $11.81B | 76.73% |
2010-01-31 | $15.45B | $11.72B | 75.85% |
2009-10-31 | $15.09B | $11.43B | 75.70% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $105.535B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
Stryker (SYK) | United States | $123.816B | 30.70 |
Boston Scientific (BSX) | United States | $98.780B | 32.84 |
EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
ResMed (RMD) | United States | $26.307B | 26.30 |
Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
Terumo (TRUMY) | Japan | $24.492B | 34.59 |
Baxter (BAX) | United States | $20.044B | 14.62 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.641B | 61.12 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
Demant (WILYY) | Denmark | $9.965B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
Haemonetics (HAE) | United States | $4.126B | 21.10 |
GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
Envista Holdings (NVST) | United States | $3.430B | 13.05 |
QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
Neogen (NEOG) | United States | $2.515B | 24.19 |
ICU Medical (ICUI) | United States | $2.333B | 17.41 |
TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
Owens & Minor (OMI) | United States | $1.899B | 18.23 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
InMode (INMD) | Israel | $1.462B | 7.57 |
LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
Warby Parker (WRBY) | United States | $1.185B | 0.00 |
AtriCure (ATRC) | United States | $1.122B | 0.00 |
MacroGenics (MGNX) | United States | $0.977B | 0.00 |
Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
Evolus (EOLS) | United States | $0.668B | 0.00 |
Quanterix (QTRX) | United States | $0.605B | 0.00 |
Jin Medical (ZJYL) | China | $0.600B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
Valneva SE (VALN) | France | $0.528B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
PetIQ (PETQ) | United States | $0.479B | 17.89 |
ZimVie (ZIMV) | United States | $0.420B | 25.72 |
Biote (BTMD) | United States | $0.413B | 3.93 |
OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
Surmodics (SRDX) | United States | $0.377B | 40.75 |
Zynex (ZYXI) | United States | $0.366B | 42.15 |
Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Veru (VERU) | United States | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
High Tide (HITI) | Canada | $0.179B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.101B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.091B | 0.00 |
Brainsway (BWAY) | Israel | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
United Health Products (UEEC) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.30 |
Modular Medical (MODD) | United States | $0.036B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |